bioAffinity Techn…
USUSDbioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 1. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte Kohta
- Veebileht
- bioaffinitytech.com
- Investorite Suhted
- bioaffinitytech.com/contact/
- Sektor
- Health Care · Biotechnology: Commercial Physical & Biological Resarch
- Peakontor
- SAN ANTONIO, United States
- Tegevjuht
- Maria Zannes
- Töötajad
- 57
- Ringluses Olevad Aktsiad
- 8.1 mln seisuga 2026-08-03
- Vabalt Kaubeldavad Aktsiad
- 532 257
- Turukapitalisatsioon
- 3.69 mln USD
- Siseringi Isikud
- 0.82%
- Institutsionaalsed Investorid
- 5.62%
- Tegevusala (SIC)
- Services-Commercial Physical & Biological Research
- P/E
- kahjum
- FCF
- −11.6 mln USD
- Võlg
- 36.5 tuh USDnetoraha
- Kasum ja FCF — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
- NAV
Kirjeldus
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Börsid ja Tikkerid
| Börs | Tikker | Valuuta | Hind | Tüüp |
|---|---|---|---|---|
| US USA Stocks | BIAF | USD | 3.57 -2.46% | tavalised aktsiad |
Selle Nädala Uudised
Pressiteated ettevõtte investorite veebisaidilt, uuendatakse iga päev. Lingid viivad ettevõtte veebilehele. Pealkirjad on originaalkeeles, nagu ettevõtte veebilehel.
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| ZANNES MARIA (Chief Exec… | ≈46.94% | 280 359 | 2025-01-10 |
| EDWARDS JAMES MICHAEL CP… | ≈20.11% | 120 128 | 2025-01-10 |
| ZANNES TIMOTHY PETER (Ge… | ≈9.17% | 54 765 | 2025-01-10 |
| REVELES XAVIER TRINIDAD… | ≈7.02% | 41 943 | 2025-01-10 |
| Sabby Management, LLC | 4.06% | 24 377 | 2026-06-30 |
| Blackrock Inc. | 1.1% | 6 585 | 2026-06-30 |
| Vanguard Capital Managem… | 0.62% | 3 703 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.62% | 3 703 | 2026-06-30 |
| Geode Capital Management… | 0.57% | 3 398 | 2026-06-30 |
| J. Safra Sarasin Holding… | 0.47% | 2 840 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.34% | 2 071 | 2026-06-30 |
| Susquehanna Internationa… | 0.3% | 1 791 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 1 786 | 2026-06-30 |
| Fidelity Concord Street… | 0.28% | 1 659 | 2026-07-31 |
| State Street Corporation | 0.27% | 1 606 | 2026-06-30 |
| HRT Financial LP | 0.23% | 1 389 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 509 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 434 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 167 | 2026-07-31 |
| GIRGENTI STEVEN (Officer… | — | 1.09 mln | 2025-01-10 |
Logi Sisse Google